These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 7360363

  • 1. [Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine].
    Luporini G, Labianca R, Fraschini P, Tedeschi L.
    Minerva Med; 1980 Mar 17; 71(10):773-9. PubMed ID: 7360363
    [No Abstract] [Full Text] [Related]

  • 2. Treatment with 5-FU, VCR and BCNU in tumor bearing nude mice.
    Köhler L, Schmitz R, Mennigen R, Fuchshuber P, Eypasch E.
    Strahlenther Onkol; 1989 Jul 17; 165(7):542-4. PubMed ID: 2749493
    [No Abstract] [Full Text] [Related]

  • 3. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].
    Scanni A, Tomirotti M, Biraghi M, Annibali E, Del Bianco S.
    Minerva Med; 1980 Mar 17; 71(10):799-801. PubMed ID: 7360368
    [No Abstract] [Full Text] [Related]

  • 4. Clinical trial of BCNU (NSC-409962) combined with vincristine (NSC-67574) in disseminated gastrointestinal cancer and other neoplasms.
    Stolinsky DC, Pugh RP, Bohannon RA, Bogdon DL, Bateman JR.
    Cancer Chemother Rep; 1974 Mar 17; 58(6):947-50. PubMed ID: 4614902
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Late results of the prophylactic treatment with 5-fluorouracil of cancer of the large intestine and rectum].
    Blokhina NG.
    Klin Med (Mosk); 1976 Aug 17; 54(8):58-63. PubMed ID: 1011775
    [No Abstract] [Full Text] [Related]

  • 8. [TAC-278. A new 5-FU derivative, by the oral route for its efficacy and safety in 36 patients with advanced cancers].
    Watanabe K, Satoh H, Ohki S, Furue H, Komita T, Iketa T, Ikenaga M, Arimori S, Nagao T, Yamamoto S.
    Gan To Kagaku Ryoho; 1982 Apr 17; 9(4):675-80. PubMed ID: 7184420
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
    Falkson G, van Eden EB, Falkson HC.
    Cancer; 1974 May 17; 33(5):1207-9. PubMed ID: 4595974
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB, Falkson G, van Dyk JJ, van der Merwe AM, Falkson HC.
    Cancer Chemother Rep; 1972 Feb 17; 56(1):107-47. PubMed ID: 5030803
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of large bowel cancer.
    Davis HL.
    Cancer; 1982 Dec 01; 50(11 Suppl):2638-46. PubMed ID: 6215979
    [No Abstract] [Full Text] [Related]

  • 15. A prospective trial of 5-FU and BCNU in the treatment of advanced gastric cancer.
    Jamieson GG, Gill PG.
    Aust N Z J Surg; 1981 Feb 01; 51(1):16-9. PubMed ID: 7013748
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical studies with DTIC (NSC-45388) in various malignancies.
    Slavik M.
    Cancer Treat Rep; 1976 Feb 01; 60(2):213-4. PubMed ID: 769976
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Animal experiments using adjuvant 5-FU and BCNU chemotherapy in stomach cancer].
    Knorr V, Schmitz R.
    Chirurg; 1980 Sep 01; 51(9):601-5. PubMed ID: 7460686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.